Zotoxa Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 1.40 Cr
- Revenue Growth 6.49%
- Profit Growth 3967.90%
- Ebitda 17.56%
- Net Worth 10.17%
- Total Assets -11.90%
About Zotoxa Pharma
Zotoxa Pharma Private Limited (ZPPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 13 November 2017 (Seven years and two months 19 days old ). Its registered office is in Kalol, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹1.40 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Hasmukhbhai Patel and Vipul Patel serve as directors at the Company.
Company Details
- Location
Kalol, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24100GJ2017PTC099782
- Company No.
099782
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Nov 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
What products or services does Zotoxa Pharma Private Limited offer?
Zotoxa Pharma Private Limited offers a wide range of products and services, including Sexual Wellness Products, Contraceptives, Anti Infective Drugs & Medicines, Malaria Medicine, Antibiotic Tablets, Capsule & Syrup, Cardiovascular Drugs & Medication, Diabetes Medicine, Respiratory System Drugs, Anti Asthma Drug, Common Disease Medicines.
Who are the key members and board of directors at Zotoxa Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vipul Patel  | Director | 01-Apr-2022 | Current |
| Hasmukhbhai Patel | Director | 13-Nov-2017 | Current |
Financial Performance of Zotoxa Pharma.
Zotoxa Pharma Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 6.49% increase. The company also saw a substantial improvement in profitability, with a 3967.9% increase in profit. The company's net worth Soared by an impressive increase of 10.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zotoxa Pharma?
In 2023, Zotoxa Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹14.00 M
Charges Breakdown by Lending Institutions
- Others : 1.40 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Jul 2018 | Others | ₹1.40 Cr | Satisfied |
How Many Employees Work at Zotoxa Pharma?
Unlock and access historical data on people associated with Zotoxa Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zotoxa Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zotoxa Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
